tiprankstipranks
Trending News
More News >
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
US Market

CNS Pharmaceuticals (CNSP) Income Statement

Compare
1,082 Followers

CNS Pharmaceuticals Income Statement

Last quarter (Q4 2024), CNS Pharmaceuticals's total revenue was $1.57K, a decrease of -75.32% from the same quarter last year. In Q4, CNS Pharmaceuticals's net income was $-3.18M. See CNS Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -4.13K$ -11.76K$ -13.07K$ -11.10K
Operating Expenses
$ 14.90M$ 18.87M$ 15.27M$ 14.03M$ 9.45M
Depreciation and Amortization
$ -28.02K$ 4.13K$ 11.76K$ 13.07K$ 11.10K
EBITDA
$ -14.90M$ -18.86M$ -15.26M$ -14.47M$ -9.44M
Operating Income
$ -14.90M$ -18.87M$ -15.27M$ -14.03M$ -9.45M
Other Income/Expenses
$ 44.14K$ 13.88K$ -7.03K$ -9.29K$ -3.26K
Pretax Income
$ -14.86M$ -18.85M$ -15.27M$ -14.04M$ -9.46M
Net Income
$ -14.86M$ -18.85M$ -15.27M$ -14.50M$ -9.46M
Per Share Metrics
Basic EPS
$ -38.87$ -251.35$ -560.83$ -852.66$ -859.81
Diluted EPS
$ -38.87$ -250.19$ -560.83$ -825.04$ -853.68
Weighted Average Shares Outstanding
38.22M 75.00K 27.23M 17.00M 11.00M
Weighted Average Shares Outstanding (Diluted)
38.22M 75.35K 27.23M 17.57M 11.08M
Currency in USD

CNS Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis